- About Lipotriad Vitamins ▾
- Products ▾
- Global Export
- Contact us ▾
- Dr. Center
- Sign in
- About Lipotriad Vitamins
- Contact us
The Age-Related Eye Disease Study (AREDS) is a major clinical trial sponsored by the National Eye Institute, one of the Federal government's National Institutes of Health. The study took 6 1/2 years and involved 4,757 participants, 55-80 years of age, in 11 clinical centers nationwide.
The AREDS was designed to learn more about the natural history and risk factors of age-related macular degeneration (AMD) and cataract and to evaluate the effect of high doses of antioxidants and zinc on the progression of AMD and cataract.
Results from the AREDS showed that high levels of antioxidants and zinc significantly reduce the risk of advanced AMD and its associated vision loss. These same nutrients had no significant effect on the development or progression of cataract.
Scientists found that people at high risk of developing advanced stages of AMD, a leading cause of vision loss, lowered their risk by about 25 percent when treated with a high-dose combination of vitamin C, vitamin E, beta-carotene, and zinc. In the same high risk group -- which includes people with intermediate AMD, or advanced AMD in one eye but not the other eye -- the nutrients reduced the risk of vision loss caused by advanced AMD by about 19 percent.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, care or prevent any disease. This web site may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult with a doctor or other healthcare professional.